Etsuo Yonemochi

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Pharmaceutics

ACS nano

Acta crystallographica. Section E, Crystallographic communications

Pharmaceuticals (Basel, Switzerland)

Hoshi Yakka Daigaku

Chiba Daigaku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hoshi Yakka Daigaku Apr 1o 2013

Japan

Professor

Education History

Chiba Daigaku

Japan

PHD

Publications

Hiroki Tanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Takashi Tadokoro, Katsumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita
Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS nano (2023)
Qihui Xu, Takayuki Furuishi, Kaori Fukuzawa, Etsuo Yonemochi
Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form. Pharmaceutics 15 (2) (2023)
Qihui Xu, Takayuki Furuishi, Kaori Fukuzawa, Etsuo Yonemochi
Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form. Pharmaceutics 15 (2) (2023)
Qihui Xu, Takayuki Furuishi, Kaori Fukuzawa, Etsuo Yonemochi
Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form. Pharmaceutics 15 (2) (2023)
Hiroki Tanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Takashi Tadokoro, Katsumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita
Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS nano 17 (3) (2023)
Hiroki Tanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Takashi Tadokoro, Katsumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita
Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS nano 17 (3) (2023)
Hiroki Tanaka, Shinya Hagiwara, Daiki Shirane, Takuma Yamakawa, Yuka Sato, Chika Matsumoto, Kota Ishizaki, Miho Hishinuma, Katsuyuki Chida, Kasumi Sasaki, Etsuo Yonemochi, Keisuke Ueda, Kenjirou Higashi, Kunikazu Moribe, Takashi Tadokoro, Katsumi Maenaka, Sakura Taneichi, Yuta Nakai, Kota Tange, Yu Sakurai, Hidetaka Akita
Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA. ACS nano 17 (3) (2023)
Qihui Xu, Takayuki Furuishi, Kaori Fukuzawa, Etsuo Yonemochi
Physicochemical Properties and Transdermal Absorption of a Flurbiprofen and Lidocaine Complex in the Non-Crystalline Form. Pharmaceutics 15 (2) (2023)
Mizuki Yamada, Agata Ishikawa, Shun Muramatsu, Takayuki Furuishi, Yoshinori Onuki, Kaori Fukuzawa, Etsuo Yonemochi
Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG). Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Kazuya Sugita, Noriyuki Takata, Etsuo Yonemochi
Non-Effective Improvement of Absorption for Some Nanoparticle Formulations Explained by Permeability under Non-Sink Conditions. Pharmaceutics 14 (4) (2022)
Kazuya Sugita, Noriyuki Takata, Etsuo Yonemochi
Dose-Dependent Solubility-Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions. Pharmaceutics 13 (3) (2021)
Yuta Otsuka, Yuiko Utsunomiya, Daiki Umeda, Etsuo Yonemochi, Yayoi Kawano, Takehisa Hanawa
Effect of Polymers and Storage Relative Humidity on Amorphous Rebamipide and Its Solid Dispersion Transformation: Multiple Spectra Chemometrics of Powder X-Ray Diffraction and Near-Infrared Spectroscopy. Pharmaceuticals (Basel, Switzerland) 13 (7) (2020)
Shinji Katsura, Takayuki Furuishi, Haruhisa Ueda, Etsuo Yonemochi
Synthesis and Characterization of Cholesteryl Conjugated Lysozyme (CHLysozyme). Molecules (Basel, Switzerland) 25 (16) (2020)
Yuri Ikeuchi-Takahashi, Yudai Shiokawa, Kazuki Sekita, Etsuo Yonemochi, Hiraku Onishi
Development of microparticles coated with poly-γ-glutamic acid to improve oral absorption of a poorly water-soluble drug. Pharmaceutical development and technology 24 (8) (2019)
Takayuki Furuishi, Kohei Sekino, Mihoko Gunji, Kaori Fukuzawa, Hiromasa Nagase, Tomohiro Endo, Haruhisa Ueda, Etsuo Yonemochi
Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine. Pharmaceutical development and technology 24 (4) (2018)
Okky Dwichandra Putra, Daiki Umeda, Eriko Fujita, Tamami Haraguchi, Takahiro Uchida, Etsuo Yonemochi, Hidehiro Uekusa
Solubility Improvement of Benexate through Salt Formation Using Artificial Sweetener. Pharmaceutics 10 (2) (2018)
Daiki Umeda, Okky Dwichandra Putra, Mihoko Gunji, Kaori Fukuzawa, Etsuo Yonemochi
Epalrestat tetra-hydro-furan monosolvate: crystal structure and phase transition. Acta crystallographica. Section E, Crystallographic communications 73 (Pt 7) (2017)
Okky Dwichandra Putra, Daiki Umeda, Kaori Fukuzawa, Mihoko Gunji, Etsuo Yonemochi
A new solvate of epalerstat, a drug for diabetic neuropathy. Acta crystallographica. Section E, Crystallographic communications 73 (Pt 8) (2017)

Etsuo Yonemochi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Etsuo Yonemochi